You are here

  • Home
  • Archive
  • Volume 74, Issue 6
  • Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Authors

  1. Correspondence to Dr Ricard Cervera, Servei de Malalties Autoimmunes, Hospital Clinic, Villarroel 170, Barcelona, Catalonia 08038, Spain; rcervera{at}clinic.cat
View Full Text

Citation

Cervera R, Serrano R, Pons-Estel GJ on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies), et al
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
Annals of the Rheumatic Diseases 2015;74:1011-1018.

Publication history

  • Received October 30, 2013
  • Revised January 3, 2014
  • Accepted January 5, 2014
  • First published January 24, 2014.
Online issue publication 
November 02, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions